Signaling by the inhibitory receptor CD200R is rewired by type I interferon

Author:

van der Vlist Michiel12ORCID,Ramos M. Inês Pascoal12ORCID,van den Hoogen Lucas L.3,Hiddingh Sanne1ORCID,Timmerman Laura M.12ORCID,de Hond Titus A. P.12,Kaan Ellen D.12ORCID,van der Kroef Maarten3,Lebbink Robert Jan4ORCID,Peters Florence M. A.1ORCID,Khoury-Hanold William5ORCID,Fritsch-Stork Ruth3,Radstake Timothy R. D. J.3ORCID,Meyaard Linde12ORCID

Affiliation:

1. Center for Translational Immunology, Department of Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

2. Oncode Institute, Utrecht, Netherlands.

3. Center for Translational Immunology, Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

4. Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

5. Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.

Abstract

Type I interferon switches the receptor CD200R from inhibiting to potentiating inflammatory responses in immune cells.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Cell Biology,Molecular Biology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3